Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Lifevantage Corp reported second fiscal quarter ended December 31, 2023 results: revenue $51.6 million, net income $0.7 million, EPS $0.05 per diluted share.
- Period
- second fiscal quarter ended December 31, 2023
- Revenue
- $51.6 million
- Net income
- $0.7 million
- EPS
- $0.05 per diluted share
- Result
- reported results
Exact text from the filing
Second Quarter Fiscal 2024 Summary*: • Revenue of $51.6 million, a decrease of 3.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was down approximately 3.4%; • Revenue in the Americas decreased 1.6%, and revenue in Asia/Pacific & Europe decreased 10.0%. Excluding the negative impact of foreign currency fluctuations, second quarter revenue in Asia/Pacific & Europe decreased approximately 8.0%; • Net loss per diluted share was $0.05, versus net loss of $0.08 per diluted share a year ago; • Adjusted earnings per diluted share was $0.10, compared to adjusted loss per share of $0.07 a year ago; and • Adjusted EBITDA increased 289.0% to $3.1 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Lifevantage Corp reported fiscal year 2024 results: revenue $207 million to $213 million, EPS $0.57 to $0.67.
- Period
- fiscal year 2024
- Revenue
- $207 million to $213 million
- EPS
- $0.57 to $0.67
- Result
- guidance update
Exact text from the filing
The Company expects to generate revenue in the range of $207 million to $213 million in fiscal year 2024, down from the previous range of $216 million to $226 million, and adjusted EBITDA of $16 million to $18 million, with adjusted earnings per share in the range of $0.57 to $0.67, up from the previous range of $0.52
View on SEC.gov